Christopher J. Lafargue

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas”.

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

Nature Genetics(2009)10.1038/ng.465

N/A

1.0DataRank · unranked

949 citations

Hideo Watanabe, Craig H. Mermel, Soyoung Yu, Sven Perner, So Young Kim +48 more

CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance

Cell Reports(2021)10.1016/j.celrep.2021.109549

N/A

0DataRank · unranked

41 citations

Lingegowda S. Mangala, Wen Hu, Emine Bayaktar, Akira Yokoi, Wei Hu +19 more

Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L

Nature Communications(2023)10.1038/s41467-023-36910-5

N/A

0DataRank · unranked

42 citations

Paola Amero, Kyunghee Noh, Lingegowda S. Mangala, Yunfei Wen, Emine Bayraktar +27 more